Piotr Rieske

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 13

Top Venues

International journal of molecular sciences

Genes

Journal of oncology

Stem cell research & therapy

Medical University of Lodz

Medical University of Lodz (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Medical University of Lodz

Poland

Principal Investigator :: Tumor Biology

Medical University of Lodz

Poland

Principal Investigator :: Molecular Pathology and Neuropathology

Temple University

United States

Postdoctoral fellow :: Neurology

Medical University of Lodz

Poland

Assistant :: Molecular Pathology and Neuropathology

Hahnemann University Hospital

United States

Postdoctoral fellow :: Biochemistry

Thomas Jefferson University Jefferson School of Nursing

United States

Postdoctoral fellow :: Immunology

Medical Academy of Lodz

Poland

Assistant :: Molecular Biology

Medical Academy of Lodz

Poland

Technician :: Molecular Biology

Education History

Medical University of Lodz

Poland

MSC

Publications

Cezary Tręda, Aneta Wlodarczyk, Marcin Pacholczyk, Adrianna Rutkowska, Ewelina Stoczyńska-Fidelus, Amelia Kierasińska, Piotr Rieske
Increased EGFRvIII Epitope Accessibility after Tyrosine Kinase Inhibitor Treatment of Glioblastoma Cells Creates More Opportunities for Immunotherapy. International journal of molecular sciences 24 (5) (2023)
Cezary Tręda, Aneta Wlodarczyk, Marcin Pacholczyk, Adrianna Rutkowska, Ewelina Stoczyńska-Fidelus, Amelia Kierasińska, Piotr Rieske
Increased EGFRvIII Epitope Accessibility after Tyrosine Kinase Inhibitor Treatment of Glioblastoma Cells Creates More Opportunities for Immunotherapy. International journal of molecular sciences 24 (5) (2023)
Cezary Tręda, Aneta Wlodarczyk, Marcin Pacholczyk, Adrianna Rutkowska, Ewelina Stoczyńska-Fidelus, Amelia Kierasińska, Piotr Rieske
Increased EGFRvIII Epitope Accessibility after Tyrosine Kinase Inhibitor Treatment of Glioblastoma Cells Creates More Opportunities for Immunotherapy. International journal of molecular sciences 24 (5) (2023)
Cezary Tręda, Aneta Wlodarczyk, Marcin Pacholczyk, Adrianna Rutkowska, Ewelina Stoczyńska-Fidelus, Amelia Kierasińska, Piotr Rieske
Increased EGFRvIII Epitope Accessibility after Tyrosine Kinase Inhibitor Treatment of Glioblastoma Cells Creates More Opportunities for Immunotherapy. International journal of molecular sciences 24 (5) (2023)
Urszula Smyczynska, Marcin Stanczak, Miljan Kuljanin, Aneta Włodarczyk, Ewelina Stoczynska-Fidelus, Joanna Taha, Bartłomiej Pawlik, Maciej Borowiec, Joseph D Mancias, Wojciech Mlynarski, Piotr Rieske, Wojciech Fendler, Agnieszka Zmyslowska
Proteomic and Transcriptomic Landscapes of Alström and Bardet-Biedl Syndromes. Genes 13 (12) (2022)
Urszula Smyczynska, Marcin Stanczak, Miljan Kuljanin, Aneta Włodarczyk, Ewelina Stoczynska-Fidelus, Joanna Taha, Bartłomiej Pawlik, Maciej Borowiec, Joseph D Mancias, Wojciech Mlynarski, Piotr Rieske, Wojciech Fendler, Agnieszka Zmyslowska
Proteomic and Transcriptomic Landscapes of Alström and Bardet-Biedl Syndromes. Genes 13 (12) (2022)
Dagmara Grot, Katarzyna Wasiak, Jerzy Tyszkowski, Ewelina Stoczyńska-Fidelus, Tomasz P Ochedalski, Piotr Rieske
Regeneration difficulties in patients with FQAD can limit the use of iPSc-based cell therapy. Stem cell research & therapy 13 (1) (2022)
Urszula Smyczynska, Marcin Stanczak, Miljan Kuljanin, Aneta Włodarczyk, Ewelina Stoczynska-Fidelus, Joanna Taha, Bartłomiej Pawlik, Maciej Borowiec, Joseph D Mancias, Wojciech Mlynarski, Piotr Rieske, Wojciech Fendler, Agnieszka Zmyslowska
Proteomic and Transcriptomic Landscapes of Alström and Bardet-Biedl Syndromes. Genes 13 (12) (2022)
Aneta Wlodarczyk, Cezary Tręda, Adrianna Rutkowska, Dagmara Grot, Weronika Dobrewa, Amelia Kierasińska, Marta Węgierska, Tomasz Wasiak, Tadeusz Strózik, Piotr Rieske, Ewelina Stoczyńska-Fidelus
Phenotypical Flexibility of the EGFRvIII-Positive Glioblastoma Cell Line and the Multidirectional Influence of TGFβ and EGF on These Cells-EGFRvIII Appears as a Weak Oncogene. International journal of molecular sciences 23 (20) (2022)
Urszula Smyczynska, Marcin Stanczak, Miljan Kuljanin, Aneta Włodarczyk, Ewelina Stoczynska-Fidelus, Joanna Taha, Bartłomiej Pawlik, Maciej Borowiec, Joseph D Mancias, Wojciech Mlynarski, Piotr Rieske, Wojciech Fendler, Agnieszka Zmyslowska
Proteomic and Transcriptomic Landscapes of Alström and Bardet-Biedl Syndromes. Genes 13 (12) (2022)
Paweł Głowacki, Piotr Rieske
Application and Design of Switches Used in CAR. Cells 11 (12) (2022)
Aneta Wlodarczyk, Dagmara Grot, Ewelina Stoczyńska-Fidelus, Piotr Rieske
Gaps and Doubts in Search to Recognize Glioblastoma Cellular Origin and Tumor Initiating Cells. Journal of oncology 2020 (2020)
Adrianna Rutkowska, Ewelina Stoczyńska-Fidelus, Karolina Janik, Aneta Wlodarczyk, Piotr Rieske
EGFRvIII: An Oncogene with Ambiguous Role. Journal of oncology 2019 (2019)

Piotr Rieske.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Piotr Rieske